Litcius/Paper detail

Real-World Outcomes of Ruxolitinib Treatment for Polycythemia Vera

Alexander Coltoff, Ruben A. Mesa, Jason Gotlib, Jessica Shulman, Raajit K. Rampal, Olivia Siwoski, Abdulraheem Yacoub, Alison R. Moliterno, Anna Yang, Evan M. Braunstein, Aaron T. Gerds, Gabriela Hobbs, Elliott F. Winton, Swati Goel, Martha Wadleigh, Douglas Tremblay, Erin Moshier, John Mascarenhas

2020Clinical Lymphoma Myeloma & Leukemia17 citationsDOIOpen Access PDF

Topics & Concepts

RuxolitinibPhlebotomyMedicineInternal medicinePopulationMyelofibrosisTolerabilityAdverse effectClinical trialPolycythemia veraConfidence intervalHematologySurgeryEnvironmental healthBone marrowMyeloproliferative Neoplasms: Diagnosis and TreatmentErythropoietin and Anemia TreatmentPlatelet Disorders and Treatments
Real-World Outcomes of Ruxolitinib Treatment for Polycythemia Vera | Litcius